Transcatheter heart valve repair and replacement have reshaped how structural heart disease is treated, and the market is ...
The transcatheter mitral valve replacement (TMVR) market is projected to grow at a CAGR of 20% over the forecast period. Major factors driving growth include increased prevalence of mitral valve ...
Abbott Laboratories ABT recently received Food and Drug Administration (“FDA”) approval for its Tendyne transcatheter mitral valve replacement (TMVR) system. The Tendyne system replaces mitral valves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback